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Background: The purpose of this study was to determine the validity of the SC-StepRx pedometer to assess
moderate and vigorous physical activity during treadmill walking and running in a heterogeneous sample of
children and youth aged 10-17 years.
Methods: Physical activity intensity assessed via indirect calorimetry served as the criterion standard. A convenience
sample of 40 participants (20 boys, 20 girls) wore 6 SC-StepRx pedometers, 2 ActiGraph GT3X accelerometers, 2
Actical accelerometers, 1 Walk4Life MVP pedometer and 1 NL-1000 pedometer while walking/running at speeds
approximating 2, 3, 4, 6 and 7 METs. Associations between indirect calorimetry and each activity monitor were
assessed using linear regression analyses in SAS 9.2.
Results: Estimates of moderate and vigorous physical activity from all monitors were significantly associated with
the criterion standard of indirect calorimetry. The strongest associations with the criterion measure were observed for
the SC-StepRx with moderate/vigorous thresholds of 110/130 steps•minute−1, and the NL-1000 (R2 = 0.82, p <0.05). The
SC-StepRx with moderate/vigorous thresholds of 110/130 steps•minute−1 also exhibited the highest combined
sensitivity (92.9%) and specificity (96.5%) for correctly identifying a bout of moderate-to-vigorous physical activity.
Conclusions: This study demonstrates that the SC-StepRx pedometer is a valid tool for the measurement of moderate
and vigorous physical activity in children and youth.
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High levels of physical activity are positively associated with
both physical and mental health in children (aged < 12 years
[1]) and youth (aged 12–17 years [1]) [2]. Pedometers,
which measure the number of steps taken by an individual,
are a common tool for the assessment of physical activity in
the pediatric age group [3-5]. However, while traditional pe-
dometers are able to provide an estimate of a child’s global
physical activity level (e.g. steps•day−1), they are unable to* Correspondence: saunders.travis@gmail.com
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unless otherwise stated.determine whether that activity was performed at a light,
moderate, or vigorous intensity. This is a major shortcom-
ing, as health outcomes are more closely associated with
moderate (MPA) and vigorous (VPA) physical activity than
with light physical activity in pediatric populations [2]. Fur-
ther, without the ability to assess MPA and VPA, pedome-
ters have thus far been unable to determine whether a child
meets Canada’s Physical Activity Guidelines [1].
To overcome this limitation, several companies have
introduced pedometers that are capable of recording time
spent engaging in MPA, VPA, or combined moderate and
vigorous physical activity (MVPA). These pedometers
include the SC-StepRx (StepsCount Inc, Deep River, ON,
Canada), NL-1000 (New-Lifestyles Inc, Lees Summit, MO,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Saunders et al. BMC Public Health 2014, 14:519 Page 2 of 9
http://www.biomedcentral.com/1471-2458/14/519USA) and the Walk4Life MVP (Walk4Life, Plainfield, IL,
USA). Previous studies have examined the convergent
validity of pedometer- and accelerometer-based estimates
of MVPA in children and youth [6,7]. However, to our
knowledge no study has examined the validity of
pedometer-based estimates of MVPA in comparison to
the more robust criterion standard of indirect calorimetry.
Thus, the purpose of the current study was to determine
the validity of the SC-StepRx pedometer to determine
MPA, VPA, and MVPA during treadmill walking and run-
ning in a heterogeneous sample of children and youth
aged 10-17 years. A secondary purpose of this study was
to compare the performance of the SC-StepRx with that
of the NL-1000 and Walk4Life MVP pedometers, as
well as the Actical (Philips Respironics, OR, USA) and




A convenience sample of 40 participants between the
ages of 10 and 17 years participated in this study. Partic-
ipants under the age of 10 were excluded as it was felt
that younger participants would not be able to follow
the testing protocol (e.g. maintaining a consistent step-
ping cadence at various intensities). Informed consent
was obtained from participants 16 years of age or older,
while parent consent and participant assent were obtained
for those under 16 years. Participants were required to
complete a health screening questionnaire; be between
the ages of 10 and 17 years; and complete at least 4 of
the 5 treadmill stages. Research ethics board approval
was obtained from the Children’s Hospital of Eastern
Ontario Research Institute.
Participants were instructed to abstain from vigorous
exercise for 12 hours prior to the testing session, and to
avoid all food, drink (except water), caffeine and nicotine
for the 2 hours immediately prior to testing. Thirty-two
of the 40 participants completed all 5 stages of the tread-
mill protocol. Four participants exceeded 2 METs at the
lowest treadmill speed (0.8 km.h-1), and therefore did not
complete Stage 1. Four participants were unable to main-
tain the intensity chosen for the final stage (7 METs), and
therefore did not complete Stage 5. Participants who did
not complete a stage had values set to missing for that
particular stage, and were included in all other analyses.
A wall-mounted stadiometer (Seca, Hanover, MD, USA)
was used to measure standing and sitting heights to
the nearest 0.1 cm, and a digital scale (Seca, Hanover,
MD, USA) was used to measure weight to the nearest
0.1 kg for all participants. Leg length was derived from
sitting and standing heights. Weight status was deter-
mined according to growth charts published by the World
Health Organization [8]. Participants who fell more than 1standard deviation above the growth standard median for
their age and gender were considered overweight, and
those more than 2 standard deviations above the median
were considered obese. Self-rated fitness was assessed by
asking participants to indicate on a questionnaire whether
their fitness was very good, good, average, poor or very
poor. This was based on a similar question in the Canadian
Society for Exercise Physiology Physical Activity, Fitness
and Lifstyle Approach (CPAFLA) [9] which has not yet
been validated. Self-rated fitness has therefore been in-
cluded only for descriptive purposes.
Treadmill protocol
The testing protocol was based on a previous study,
which examined the validity of the SC-StepMX pedometer
to record steps in a heterogeneous sample of children
and youth [10]. Participants in the current study wore 6
SC-StepRx pedometers, 2 ActiGraph GT3X accelerometers,
2 Actical accelerometers, 1 NL-1000 pedometer and 1
Walk4Life MVP pedometer (Figure 1). The monitors
were evenly spaced on the left and right sides of the body
on a belt, and were placed in the same relative positions
for all participants.
Participants performed 5 separate 5-minute stages of
increasing intensity, with treadmill speeds chosen to ap-
proximate 2, 3, 4, 6, and 7 METs, respectively. All stages
were performed with a treadmill elevation of 0%. The
mean MET value for each stage was determined by aver-
aging energy expenditure during the final 3 minutes of
the stage, as determined via indirect calorimetry using a
MedGraphics Ultima metabolic cart (MedicalGraphics
Corporation, St. Paul, MN, USA). This served as the
criterion measure for exercise intensity, with MPA and
VPA corresponding to energy expenditures exceeding
4 and 7 METs, respectively [11]. Participants walked or
ran on the treadmill for 1–2 minutes prior to each stage
in order to determine the treadmill speed approximating
the appropriate energy expenditure. Once the appropriate
treadmill speed was determined, participants were asked
to straddle the treadmill belt while researchers reset all
pedometers to zero. Participants then walked or ran at
the chosen speed for 5 minutes. Two examiners manu-
ally counted and recorded steps during the 3rd and 5th
minute of each stage using hand-tally counters. The
counts of the two examiners were then averaged, which
provided the criterion measure for steps. A video record-
ing was also made of each stage to permit examiners to
re-count steps whenever they believed they had made an
error in counting. If an examiner believed that an error
had taken place, they left the field blank on their scoring
sheet during the testing session. After the testing session
was complete an examiner used the video to count the
steps at the stage with the missing value using the same
protocol as above; this new value was then entered into




















Figure 1 Placement of the physical activity monitors.
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stages, there were 14 instances when such an error took
place. The mean difference between the two examiners
was 0.4 steps•minute−1, while the greatest absolute dif-
ference between examiners at any individual stage was
3 steps•minute−1. Across all stages the correlation between
the two examiners was R2=0.998.
Ratings of perceived exertion [12] were indicated by
participants during the 4th minute of each stage. At the
conclusion of each stage the number of steps and mi-
nutes of MPA and VPA were recorded for each pedom-
eter (the NL-1000 records only total MVPA, and therefore
only MVPA was recorded for this activity monitor). Across
all time points and monitors, there were 9 specific instances
where a pedometer showed evidence that it was not reset
prior to a stage (steps > 2 standard deviations from the
mean for that stage, and MPA or VPA values which were
substantially larger than possible in a 5 minute stage). In
these 9 instances the values for the affected pedometer
were set to missing for the affected time points.
Activity monitors & data processing
The current study tested 5 different activity monitors
concurrently. This included 3 pedometers (the SC-StepRx,
the NL-1000 and the Walk4Life MVP) and 2 accelerome-
ters (The ActiGraph GT3X and the Actical). All 3 pedome-
ters investigated in the current study assess moderate and
vigorous physical activity, which is displayed on an LCD
screen. The SC-StepRx and the NL-1000 are both piezo-
electric pedometers, while the Walk4Life MVP employs a
triaxial accelerometer. All three pedometers had similar di-
mensions. The width, height and depth of the SC-StepRx
were 5 cm, 3 cm and 1.5 cm, respectively. The dimensions
of the NL-1000 are 6.4 cm × 3.8 cm × 2.2 cm, while those
of the Walk4Life MVP are 5.7 cm × 3.2 cm × 1.3 cm.
Neither the Actigraph nor Actical have a screen, there-
fore data from these devices must be downloaded afteran activity bout. The ActiGraph accelerometer is a triaxial
accelerometer, which has physical dimensions of 3.8 cm ×
3.7 cm × 1.8 cm while the Actical is an omnidirectional
accelerometer with physical dimensions of 2.8 cm ×
2.7 cm × 1.0 cm.
The activity monitors used in the present study allow
the user to modify the specific thresholds used to determine
MPA and VPA. For pedometers this is done prior to the ac-
tivity bout, while for accelerometers it is done during data
processing. In the current study two SC-StepRx pedometers
(one on each side of the body) were set to moderate/
vigorous intensity thresholds of 100/120 steps•minute−1,
two SC-StepRx pedometers were set to moderate/vigorous
thresholds of 110/130 steps•minute−1, while the final
two were set to thresholds of 120/140 steps•minute−1.
The Walk4Life pedometer was set to moderate/vigorous
thresholds of 100/120 steps•minute−1, while the NL-1000
pedometer was set to an internal setting of 4–9, which the
manufacturer claims is equivalent to 3.6 METs [7]. The
settings for all pedometers were confirmed immediately
prior to each testing session.
Both Actical and ActiGraph accelerometers were ini-
tialized to collect data using 15-second epochs, and
collected data on both the number of steps•minute−1
and movement intensity. The low frequency extension
was used for the ActiGraph accelerometer for all par-
ticipants [13]. Actical accelerometer cut-points of 1500
and 6500 counts per minute were used to identify MPA
and VPA, respectively [14]. ActiGraph data were ana-
lyzed using three separate pediatric cut-points; those
suggested by Evenson [15], Treuth [16], and Freedson
[16,17]. The Evenson cut-points employ thresholds of
2296 and 4012 counts per minute for MPA and VPA,
respectively [15], while the Treuth cut-points employ
thresholds of 3000 and 5200 counts per minute [16].
Finally, the cut-points developed by Freedson’s group
are age-dependent [16,17].






Age (years) 13.5 (1.5) 13.7 (2.3) 0.55
Height (cm) 161.2 (11.9) 157.9 (11.9) 0.36
Weight (kg) 57.9 (18.8) 53.9 (14.1) 0.45
Leg length (cm) 80.6 (5.8) 81.9 (18.3) 0.76
BMI (kg/m2) 21.9 (5.5) 22.3 (3.6) 0.65
Proportion overweight or obese 7/20 5/20
Overweight 4/20 4/20 1.00
Obese 3/20 1/20 0.29
Self-rated fitness
Very good 6/20 7/20 0.74
Good 10/20 5/20 0.10
Average 3/20 8/20 0.08
Poor 1/20 0/20 0.31
Very poor 0/20 0/20 1.00
Data are presented as mean (SD). Statistical significance assessed using
independent t-tests for continuous variables, and chi-square test for proportions.
Overweight and obesity status determined using WHO Growth Charts [8].
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All statistical analyses were performed using SAS 9.2
(SAS Institute Inc, Cary, NC, USA). Data are presented
as mean (standard deviation) unless otherwise noted.
Mean steps and minutes of MPA, VPA and MVPA were
averaged across monitors (within intensity stage) of the
same brand and internal settings. The performance of
monitors on the left and right sides of the body (within
a given brand and intensity stage) were compared using
a paired samples t test. Baseline differences between
male and female participants were assessed using an in-
dependent samples t test for continuous variables and
using the Chi-square test for proportions.
Coefficients of determination (R2) were calculated
from linear regression analyses to determine the strength
of the relationship between the output of each monitor
and the criterion measure. With respect to step counts,
the criterion measure was manually counted steps. With
respect to MPA, VPA and MVPA, the criterion measure
was minutes of MPA, VPA and MVPA determined using
the metabolic cart. Values of MPA, VPA and MVPA
were also dichotomized in order to calculate the sensi-
tivity and specificity of each monitor at each treadmill
stage. Using data from the metabolic cart, a stage was
considered MPA if the average energy expenditure over
the final three minutes of the stage was above 4 METs.
Similarly, a stage was considered VPA if the energy ex-
penditure averaged greater than 7 METs. For the activity
monitors, a stage was considered MPA if the monitor in-
dicated that ≥ 80% of the stage (e.g. 4 minutes) was spent
in MPA. Similarly, a stage was considered VPA if the
monitor indicated that ≥ 80% of the stage was spent in
VPA. A stage was considered MVPA if the monitor indi-
cated that ≥ 80% of the stage was spent in some combin-
ation of MPA and VPA.
Bias was calculated as the difference between the mi-
nutes of MVPA recorded via each activity monitor and
those recorded via the metabolic cart. Correlation ana-
lyses were used to determine whether age, body mass
index (BMI), leg length or treadmill speed was associ-
ated with bias for each monitor and intensity threshold.
Measurement bias was also plotted by treadmill speed.
Results
Participant characteristics are presented in Table 1. There
were no significant differences between male and female
participants with respect to age, anthropometric measures,
or self-rated fitness. Speed, steps and energy expenditure at
each stage are presented in Table 2. The average coefficient
of variation for manually counted steps was 0.6%, and
ranged from 0 to 5.2%. Across all stages, the lowest speed
observed for any individual participant was 0.8 km.h−1
(Stages 1 and 2), while the highest speed was 8.5 km.h−1
(Stage 5). The mean (SD) stepping cadence of MPA was125 (52) steps•min−1, while the mean (SD) cadence of VPA
was 146 (55) steps•min−1. No differences were observed in
estimates for steps, MPA or VPA when comparing moni-
tors on the right and left sides of the body (all p > 0.05).
The ratio of activity monitor step counts to manual step
counts are presented in Table 3.
The correlation between manually counted steps and
those obtained from activity monitors are presented in
Table 4. When all stages were combined, all monitors
showed significant associations with manually counted
steps, with coefficients of determination ranging from 0.86
(Actical and ActiGraph GT3X) to 0.89 (Walk4Life MVP)
(all p < 0.05). With the exception of the NL-1000 and
Actical during Stage 1 and the Actigraph at Stage 3,
steps measured via activity monitors were significantly
associated with manually counted steps at all stages,
while the observed coefficients of determination tended
to increase with treadmill speed for each monitor. There
was 1 participant whose pedometer-derived steps at
Stage 3 were much lower than for other participants
(this was consistent across devices), despite having
similar MET values at this stage. When this participant
was removed the R2 values for Stage 3 increased sub-
stantially (e.g. from 0.3 to 0.8) for the SC-StepRx, with
more modest increases for the Walk4Life and NL-1000
(e.g. from 0.2 to 0.6, and from 0.3 to 0.5, respectively), with
little change for the Actical (e.g. 0.19 to 0.24) and no
change for the Actigraph. However, given that the purpose
of the present study was to examine the accuracy of activity
monitors in a heterogeneous sample, we found no legitim-
ate reason to exclude this participant from the analysis.











SC-StepRx Walk4Life NL-1000 Actical ActiGraph
1 1.0 (0.3) 0.6 (0.2) 2.3 (0.3) 8.05 (1.1) 7 (1) 284 (68) 23 (63) 50 (50) 5 (16) 5 (20) 168 (99)
2 2.2 (0.7) 1.4 (0.4) 2.9 (0.2) 10.2 (0.7) 8 (2) 416 (56) 319 (155) 262 (145) 193 (178) 175 (155) 341 (115)
3 3.8 (0.8) 2.4 (0.5) 3.8 (0.3) 13.3 (1.1) 9 (2) 524 (40) 514 (72) 496 (97) 491 (93) 447 (136) 502 (83)
4 5.9 (0.7) 3.7 (0.4) 5.8 (0.5) 20.3 (1.8) 11 (3) 634 (39) 637 (38) 638 (41) 638 (37) 620 (39) 626 (41)
5 6.5 (1.0) 4.1 (0.6) 7.3 (0.7) 25.6 (2.5) 13 (3) 701 (65) 703 (64) 705 (63) 687 (128) 689 (62) 691 (62)
Data are presented as mean (SD). EE: energy expenditure; RPE: rating of perceived exertion.
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monitor-determined MPA, VPA and MVPA are shown
in Table 5. Significant associations were observed for
all monitors and thresholds when examining MVPA,
with coefficients of determination ranging from 0.64
(SC-StepRx set to moderate/vigorous thresholds of 100/120
steps•minute−1) to 0.82 (NL-1000, and SC-StepRx set to
moderate/vigorous thresholds of 110/130 steps•minute−1).
All associations remained significant when MPA and
VPA were analyzed separately, with the exception of the
SC-StepRx and Walk4Life MVP pedometers using an MPA
threshold of 100 steps•minute−1.
The sensitivity and specificity of each monitor for
detecting MPA, VPA and MVPA are presented in Table 6.
The highest overall sensitivity and specificity for detecting
MPA were observed for the Actical accelerometer
(Sensitivity: 80.3; Specificity: 84.1). The highest overall
sensitivity and specificity for both VPA (Sensitivity: 100.0;
Specificity: 88.6) and MVPA (Sensitivity: 92.9; Specificity:
96.5) were observed for the SC-StepRx set to moderate/
vigorous thresholds of 110/130 steps•minute−1.
The bias results for MVPA relative to treadmill speed
are presented for pedometers and accelerometers in
Figures 2 and 3, respectively. Across all monitors, the
most narrow limits of agreement were seen for the SC-
StepRx with moderate/vigorous thresholds of 110/130
steps•minute−1. In correlation analyses bias was not
associated with age, BMI, weight status, leg length or
treadmill speed when examining SC-StepRx pedometers set
to moderate/vigorous thresholds of 100/120 steps•minute−1Table 3 Ratio of activity monitor steps to manually





1 8.1 17.6 1.8 1.8 59.2
2 76.7 63.0 46.4 42.1 82.0
3 98.1 94.7 93.7 85.3 97.7
4 100.5 100.6 100.6 97.3 98.7
5 100.3 100.6 98.0 98.3 98.6
Data are presented as percentages, with activity monitor steps as the
numerator and manually counted steps as the denominator.or 110/130 steps•minute−1, NL-1000 pedometers, or
ActiGraph GT3X accelerometers using Evenson or
Freedson cut-points (all p >0.05). When examining
SC-StepRx pedometers set to moderate/vigorous thresholds
of 120/140 steps•minute−1, bias was negatively associated
with treadmill speed only (r = −0.171, p = 0.02). Bias of
the Walk4Life MVP with moderate/vigorous thresholds
of 100/120 steps•minute−1 was positively associated with
BMI only (r = 0.145, p = 0.04). Bias of the Actical acceler-
ometer was associated with BMI (r = 0.171, p = 0.02) and
weight status (0.162, p = 0.03). Using the Treuth cut-points,
bias of the ActiGraph GT3X was associated with age only
(r = 0.168, p = 0.02).
Discussion
The results of the present study suggest that the SC-StepRx
demonstrates validity for the measurement of MPA, VPA
and MVPA compared to values determined via indirect
calorimetry. When set to moderate/vigorous thresholds of
110/130 steps•min−1, the association between SC-StepRx
and metabolic cart-determined MPA, VPA and MVPA
were comparable or greater than those observed for other
pedometers or accelerometers. Similarly, using moderate/
vigorous thresholds of 110/130 steps•min−1, the SC-StepRx
had the highest combined sensitivity and specificity for
detecting MVPA and the narrowest limits of agreement
of any monitor in the current study.
To our knowledge, this is the first study to directly
compare values of MPA, VPA and MVPA determinedTable 4 Coefficients of determination (R2) between each





1 0.21* 0.33* 0.05 0.09 0.21*
2 0.35* 0.29* 0.40* 0.30* 0.19*
3 0.37* 0.23* 0.30* 0.19* 0.09
4 0.98* 0.94* 0.97* 0.93* 0.87*
5 0.99* 0.98* 0.99* 0.97* 0.95*
Overall 0.88* 0.89* 0.87* 0.86* 0.86*
*statistically significant association, p <0.05.
Table 5 Coefficients of determination (R2) between each







SC-StepRX (100, 120) 0.01 0.25* 0.64*
SC-StepRX (110, 130) 0.36* 0.45* 0.82*
SC-StepRX (120, 140) 0.59* 0.51* 0.74*
Walk4Life MVP (100, 120) 0.01 0.25* 0.69*
NL-1000 (4–9) - - 0.82*
Actical 0.45* 0.24* 0.78*
ActiGraph GT3X (Evenson) 0.09* 0.21* 0.71*
ActiGraph GT3X (Treuth) 0.29* 0.18* 0.77*
ActiGraph GT3X (Freedson) 0.37* 0.18* 0.81*
*statistically significant association, p <0.05.
PA: Physical activity.
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Previous studies have instead compared MVPA values
determined via pedometer with those determined via
accelerometry [6,7]. The current findings illustrate the
potential drawbacks to such an approach. For example,
Duncan et al. [7] have recently reported that the NL-1000
pedometer showed a low level of precision for MVPA,
when compared to the Actical accelerometer in a group of
children aged 5–11 years. In contrast, in the present study
the NL-1000 and Actical displayed comparable levels of
association, sensitivity, specificity, and limits of agreement
with the criterion measure of indirect calorimetry.
In the current study, we observed relatively small associa-
tions between bias and age, BMI, leg length, and treadmill
speed for all activity monitors. It is not surprising that bias
for all monitors tended to cluster around the treadmill
speeds associated with exercise intensities just above
and below the threshold for MVPA. It is possible that
this bias could be reduced by determining the stepping
cadence associated with MVPA for individual participants,
although such an approach may be overly onerous for mostTable 6 Sensitivity and specificity of each activity monitor for
Monitor Moderate PA
Sensitivity Specificity Se
SC-StepRx (100, 120) 16.4 89.9
SC-StepRx (110, 130) 44.3 97.1
SC-StepRx (120, 140) 27.9 98.6
Walk4Life MVP (100, 120) 16.4 91.3
NL-1000 (4–9) - -
Actical 80.3 84.1
ActiGraph GT3X (Evenson) 26.2 92.0
ActiGraph GT3X (Treuth) 39.3 92.0
ActiGraph GT3X (Freedson) 62.3 89.1
PA: Physical activity.studies. Further, the results of the present study suggest that
moderate/vigorous thresholds of 110/130 steps•minute−1
are able to minimize bias when using the SC-StepRx to
assess MVPA in the pediatric age group.
The current findings build on our previous study [10],
which found that the association between activity monitor
and manually counted steps increased with walking speed
in a group of participants ranging in age from 12–58 years.
In the current study, the association between activity
monitor and manually counted steps was relatively weak
(R2 ≤ 0.40) for all monitors during the first 3 treadmill
stages, but increased dramatically (R2 ≥ 0.87) for all
monitors at stages 4 and 5. When combined with the re-
sults of our previous study [10], these findings also sug-
gest that the ability of activity monitors to accurately
assess steps at slow speeds may be lower in children and
youth than in adults. For example, the association between
activity monitor and manually counted steps during stage
3 (mean speed = 3.8 km.h−1) of the present study displayed
a coefficient of variation of 0.37 for the SC-StepRx and
0.19 for the Actical. In contrast, similar models displayed
coefficients of variation of 0.83 and 0.59, respectively, at the
same average speed in our previous study, which included
predominantly adult participants [10]. It is therefore likely
that at slow walking speeds, step count values determined
using activity monitors in children may be less accurate
than those determined in adults.
Current evidence suggests that 100 steps•minute-1
represents a useful threshold for MPA in adults [18].
Manual count data from the present study suggests that
the transition from light to moderate PA likely occurs
between 100 and 110 steps•minute-1 in children and
youth. In support of this, we found that an MPA thresh-
old of 110 steps•minute-1 had higher sensitivity and
specificity using the SC-StepRx than thresholds of 100
or 120 steps•minute-1. However, it is important to note
that the current investigation employed MPA and VPA
thresholds of 4 and 7 METs, respectively, which are lowermoderate and vigorous physical activity
Vigorous PA Moderate and Vigorous PA
nsitivity Specificity Sensitivity Specificity
100.0 74.3 98.8 84.2
100.0 88.6 92.9 96.5
45.8 98.9 77.6 99.1
95.8 77.1 97.7 87.7
- - 85.9 97.4
37.5 97.1 91.8 91.2
70.8 82.9 87.1 92.1
41.7 92.6 76.5 98.3
37.5 94.9 87.1 96.5
Figure 2 Bias at different treadmill speeds in SC-StepRx, Walk4Life MVP and NL-1000. A: SC-StepRx with moderate/vigorous thresholds of
100/120 steps•minute−1; B: SC-StepRx with moderate/vigorous thresholds of 110/130 steps•minute−1; C: SC-StepRx with moderate/vigorous
thresholds of 120/140 steps•minute−1; D: Walk4Life MVP with moderate/vigorous thresholds of 100/120 steps•minute−1; E: NL-1000 pedometer
with an internal setting of 4–9 (no units).
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ally used for adults [11]. These higher thresholds have been
suggested for use in children and youth in order to account
for their higher level of resting energy expenditure, which
decrease with both age and maturation [11,19,20]. For ex-
ample, Harrell et al. [20] have recently reported that oxygen
uptake at rest declines from 6.08 ml•kg−1•min−1 at Tanner
Stage 1 to 3.80 ml•kg−1•min−1at Tanner Stage 5. Employing
thresholds of 3 and 6 METs rather than 4 and 7 METs mayFigure 3 Bias at different treadmill speeds in the Actical and ActiGrap
using Treuth cut-points; C: ActiGraph GT3X using Evenson cut-points; D: Achave resulted in lower steps•minute-1 thresholds closer to
those observed in adults (e.g. 100 steps•minute-1).
The current study has several strengths and limitations
that warrant mention. Although several different MPA
and VPA thresholds were examined for the SC-StepRx,
only one set of thresholds was examined for the Walk4Life
MVP and the NL-1000. Given that the performance of
the Walk4Life MVP with moderate/vigorous thresholds of
100/120 steps•minute−1 was very similar to that observedh GT3X accelerometer. A: Actical accelerometer; B: ActiGraph GT3X
tiGraph GT3X using Freedson cut-points.
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http://www.biomedcentral.com/1471-2458/14/519for the SC-StepRx at the same setting, it is possible that
the Walk4Life would show similar performance at other
thresholds as well. Further investigations comparing the
SC-StepRx and Walk4Life MVP at various moderate/
vigorous thresholds to indirect calorimetry are there-
fore warranted. It should also be noted that the current
results may have been influenced by the location of each
individual activity monitor. The monitors were placed in
the same locations for all participants, meaning that the lo-
cation of the SC-StepRx was closer to the recommended
placement than that of the other monitors. However, previ-
ous studies suggest that pedometer placement has little or
no significant impact on step counts in children and youth
[21-23]. Future studies comparing pedometers should none-
theless consider randomizing the placement of activity
monitors in order to minimize any impact of placement.
The current study used a relatively small, lab-based de-
sign, with participants walking at prescribed speeds and
intensities, which allowed us to compare the performance
of multiple monitors to a criterion standard at a wide
range of exercise intensities. Other studies are needed
to validate the SC-StepRx in larger samples using a
more naturalistic design. The results of the present
study are strengthened by the inclusion of a wide range
of participant ages (10–17 years) and body sizes.
Conclusions
The present findings suggest that the SC-StepRx pedometer
is a valid tool for the assessment of MPA, VPA, and MVPA
in the pediatric age group. When employing moderate/
vigorous thresholds of 110/130 steps•minute−1, the per-
formance of the SC-StepRx was comparable or superior to
that observed from other pedometers and accelerometers.
These results suggest that the SC-StepRx may serve as an
inexpensive tool for the assessment of MVPA in clinical
and research contexts in children and youth.
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